HuGE Literature Finder
Records 1-22
|
Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia.
Blood advances 2020 Apr 4 (7): 1350-1356. Verneris Michael R, Miller Jeffrey S, Hsu Katherine C, Wang Tao, Sees Jennifer A, Paczesny Sophie, Rangarajan Hemalatha, Lee Dean A, Spellman Stephen R, Lee Stephanie |
|
External Validation of Models for KIR2DS1/KIR3DL1-informed Selection of Hematopoietic Cell Donors fails.
Blood 2020 Jan . Schetelig Johannes, Baldauf Henning, Heidenreich Falk, Massalski Carolin, Frank Sandra, Sauter Jürgen, Stelljes Matthias, Ayuk Francis, Bethge Wolfgang Andreas, Bug Gesine, Klein Stefan, Wendler Sarah, Lange Vinzenz, de Wreede Liesbeth C, Fuerst Daniel, Kobbe Guido, Ottinger Hellmut D, Beelen Dietrich W, Mytilineos Joannis, Fleischhauer Katharina, Schmidt Alexander H, Bornhauser Mart |
|
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.
PloS one 2019 14 (6): e0218945. Tordai Attila, Bors Andras, Kiss Katalin Piroska, Balassa Katalin, Andrikovics Hajnalka, Batai Arpad, Szilvasi Aniko, Rajczy Katalin, Inotai Dora, Torbagyi Eva, Lengyel Lilla, Barta Aniko, Remenyi Peter, Masszi Tam |
|
The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
HLA 2016 Jun 87 (6): 422-31. Khanuntong S, Kuptawintu P, Upaisilpsathaporn K, Poolchareon A, Bunworasate U, Hirankarn |
|
KIR repertory in patients with hematopoietic diseases and healthy family members.
BMC hematology 2016 16 25. Sugioka Daniele Kazue, Gonçalves Carlos Eduardo Ibaldo, Bicalho Maria da Gra |
|
Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.
Human immunology 2015 Oct . Misra Maneesh Kumar, Prakash Swayam, Moulik Nirmalya Roy, Kumar Archana, Agrawal Suraks |
|
Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015 Sep 21 (9): 1589-96. Sobecks Ronald M, Wang Tao, Askar Medhat, Gallagher Meighan M, Haagenson Michael, Spellman Stephen, Fernandez-Vina Marcelo, Malmberg Karl-Johan, Müller Carlheinz, Battiwalla Minoo, Gajewski James, Verneris Michael R, Ringdén Olle, Marino Susana, Davies Stella, Dehn Jason, Bornhäuser Martin, Inamoto Yoshihiro, Woolfrey Ann, Shaw Peter, Pollack Marilyn, Weisdorf Daniel, Milller Jeffrey, Hurley Carolyn, Lee Stephanie J, Hsu Kathari |
|
Comparison of the KIR3DS1/Bw4 distribution in Chinese healthy and acute myeloid leukemia individuals.
Human immunology 2015 Mar 76 (2-3): 79-82. Tao Sudan, He Yanmin, Zhang Wei, Wang Wei, He Junjun, Han Zhedong, Chen Nanying, Dong Lina, He Ji, Zhu Faming, Lv Hangj |
|
KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL.
Blood 2014 Oct 124 (17): 2744-7. Oevermann Lena, Michaelis Sebastian U, Mezger Markus, Lang Peter, Toporski Jacek, Bertaina Alice, Zecca Marco, Moretta Lorenzo, Locatelli Franco, Handgretinger Rupe |
|
KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse.
Blood 2014 Oct 124 (14): 2248-51. Babor Florian, Manser Angela R, Fischer Johannes C, Scherenschlich Nadine, Enczmann Jürgen, Chazara Olympe, Moffett Ashley, Borkhardt Arndt, Meisel Roland, Uhrberg Mark |
|
HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients.
British journal of cancer 2014 Sep 111 (6): 1080-8. Zhao X-Y, Chang Y-J, Xu L-P, Zhang X-H, Liu K-Y, Li D, Huang X |
|
Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma.
Human immunology 2014 Jul 75 (7): 673-6. Vejbaesya Sasijit, Sae-Tam Pradermchai, Khuhapinant Archrob, Srinak Duangpo |
|
Homozygosity For Killer Immunoglobin-Like Receptor Haplotype A Predicts Complete Molecular Response To Treatment With Tyrosine Kinase Inhibitors In Chronic Myeloid Leukemia Patients.
Experimental hematology 2013 Feb . La Nasa G, Caocci G, Littera R, Atzeni S, Vacca A, Mulas O, Langiu M, Greco M, Orrù S, Orrù N, Floris A, Carcassi C |
|
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.
Experimental hematology 2012 Nov 40 (11): 906-913.e1. Kreutzman Anna, Jaatinen Taina, Greco Dario, Vakkila Emmi, Richter Johan, Ekblom Marja, Hjorth-Hansen Henrik, Stenke Leif, Melo Teresa, Paquette Ron, Seggewiss-Bernhardt Ruth, Guerci-Bresler Agnés, Talbot Alexis, Cayuela Jean Michel, Mahon Francois-Xavier, Porkka Kimmo, Lipton Jeff, Partanen Jukka, Rousselot Philippe, Mustjoki Sa |
|
KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.
Leukemia 2012 Feb 26 (2): 296-302. Marin D, Gabriel I H, Ahmad S, Foroni L, de Lavallade H, Clark R, O'Brien S, Sergeant R, Hedgley C, Milojkovic D, Khorashad J S, Bua M, Alsuliman A, Khoder A, Stringaris K, Cooper N, Davis J, Goldman J M, Apperley J F, Rezvani |
|
KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
Tissue antigens 2011 Aug 78 (2): 129-38. Karabon L, Jedynak A, Giebel S, Wo?owiec D, Kielbinski M, Woszczyk D, Kapelko-Slowik K, Kuliczkowski K, Frydecka |
|
The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.
Bone marrow transplantation 2010 Oct 45 (10): 1514-21. Wu G Q, Zhao Y M, Lai X Y, Luo Y, Tan Y M, Shi J M, Li L, Zheng W Y, Zhang J, Hu X R, Jin A Y, He J S, Xie W Z, Ye X J, Cai Z, Lin M F, Huang |
|
Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.
Leukemia & lymphoma 2010 Aug 51 (8): 1580-1. Obama Kosuke, Makishima Hideki, Ishida Fumihi |
|
Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.
Leukemia research 2010 Jan 34 (1): 55-8. Zhang Yan, Wang Bo, Ye Shihui, Liu Sheng, Liu Mengli, Shen Chunmei, Teng Yan, Qi J |
|
Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.
Tissue antigens 2009 Jun 73 (6): 553-60. Middleton D, Diler A S, Meenagh A, Sleator C, Gourraud P |
|
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.
Blood 2009 Jan 113 (3): 726-32. Cooley Sarah, Trachtenberg Elizabeth, Bergemann Tracy L, Saeteurn Koy, Klein John, Le Chap T, Marsh Steven G E, Guethlein Lisbeth A, Parham Peter, Miller Jeffrey S, Weisdorf Daniel |
|
[Differential expression levels of killer immunoglobin-like receptor genotype in patients with hematological malignancies between high-risk and standard-risk groups].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2008 Aug 16 (4): 746-9. Zhao Xiang-Yu, Chang Ying-Jun, Huang Xiao-J |
- Page last reviewed:Mar 16, 2019
- Page last updated:Jun 01, 2020
- Content source: